OPTIMI IN THE NEWS: Companies sense opportunity in psychedelic legalisation

Optimi Health Corp, a Canadian drug formulator, in May harvested 300kg of “magic mushrooms” at its licensed manufacturing plant in British Columbia under a contract for Mind Medicine Australia.

Psilocybin has been extracted from the mushrooms for processing and shipment to Australia under pharmaceutical-grade protocols.

“We’re not able to disclose exactly the dollar amount of these things, but it’s definitely enough where we’re excited,” Optimi Health co-founder and chief marketing officer Dane Stevens told AAP.

ABOUT OPTIMI

(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FORWARD‐LOOKING STATEMENTS

Products do not contain psilocybin

Search
Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.